Sionna Therapeutics, Inc.

SION

$1.96B

Small Cap

NASDAQBiotechnology🇺🇸North America41 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Jul 15, 2026

29w

Drug Pipeline

Drug Name	Phase	Indication	Designations
SION-719	Phase 2	Cystic Fibrosis (CF)	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

July 2026~SION-719

Primary completion for SION-719 trial (NCT07108153) in Cystic Fibrosis (CF)

Regulatory Approvals

SION News